VYABLIS

Transdermal and adhesive skin patches for treating, alleviating or preventing the development or progression of food allergies, namely, peanut allergies in children; patches or epicutaneous systems for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating food allergies, namely, peanut allergies in children; adhesive patches or adhesive epicutaneous systems for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating food allergies, namely, peanut allergies in children; occlusive patches or occlusive epicutaneous systems for cutaneous or epicutaneous administration of powdered medical or pharmaceutical substances for treating food allergies, namely, peanut allergies in children; patches or epicutaneous systems containing a powdered preparation for medical or pharmaceutical use for treating food allergies, namely, peanut allergies in children; patches or epicutaneous systems for use in the treatment of food allergies, namely, peanut allergies in children; patches or epicutaneous systems featuring allergens for treating food allergies, namely, peanut allergies in children; pharmaceutical preparations for treating food allergies, namely, peanut allergies in children; parts and fittings for the aforesaid goods

Pads and skin patches for medical training purposes; pads and skin patches for medical use, namely for use in training medical professionals on the transdermal delivery of pharmaceuticals or medical preparations; parts and fittings for all the aforesaid goods